Marilynn A. Roff

464 total citations
7 papers, 426 citations indexed

About

Marilynn A. Roff is a scholar working on Virology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Marilynn A. Roff has authored 7 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Virology, 4 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Marilynn A. Roff's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Marilynn A. Roff is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Marilynn A. Roff collaborates with scholars based in United Kingdom, France and United States. Marilynn A. Roff's co-authors include Ronald T. Hay, Katrina Wood, Françoise Baleux, Manuel S. Rodríguez, Jean-Marc Jacqué, Fernando Arenzana‐Seisdedos, Jill L. Thompson, R. G. Downing, Graham H. Farrar and J. D. Oram and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Vaccine.

In The Last Decade

Marilynn A. Roff

7 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilynn A. Roff United Kingdom 7 206 187 162 99 97 7 426
Ramona Ilari Italy 12 382 1.9× 196 1.0× 202 1.2× 72 0.7× 91 0.9× 19 626
Shitao Zou China 16 437 2.1× 185 1.0× 134 0.8× 61 0.6× 148 1.5× 38 649
Sam H. Whiting United States 9 153 0.7× 109 0.6× 76 0.5× 59 0.6× 141 1.5× 20 361
Irene Ivhed Sweden 9 287 1.4× 42 0.2× 177 1.1× 102 1.0× 91 0.9× 12 556
Sherly Mosessian United States 8 423 2.1× 59 0.3× 75 0.5× 68 0.7× 144 1.5× 12 627
Chiara Vardabasso United States 9 740 3.6× 120 0.6× 83 0.5× 71 0.7× 159 1.6× 12 873
Brijal Desai United States 5 330 1.6× 26 0.1× 104 0.6× 143 1.4× 214 2.2× 6 494
Daniel Latreille France 6 350 1.7× 75 0.4× 32 0.2× 77 0.8× 97 1.0× 9 416
Reed Jc United States 8 312 1.5× 49 0.3× 103 0.6× 29 0.3× 149 1.5× 12 483
H. A. Turchin United States 9 163 0.8× 25 0.1× 147 0.9× 60 0.6× 134 1.4× 15 496

Countries citing papers authored by Marilynn A. Roff

Since Specialization
Citations

This map shows the geographic impact of Marilynn A. Roff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilynn A. Roff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilynn A. Roff more than expected).

Fields of papers citing papers by Marilynn A. Roff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilynn A. Roff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilynn A. Roff. The network helps show where Marilynn A. Roff may publish in the future.

Co-authorship network of co-authors of Marilynn A. Roff

This figure shows the co-authorship network connecting the top 25 collaborators of Marilynn A. Roff. A scholar is included among the top collaborators of Marilynn A. Roff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilynn A. Roff. Marilynn A. Roff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wood, Katrina, Marilynn A. Roff, & Ronald T. Hay. (1998). Defective IκBα in Hodgkin cell lines with constitutively active NF-κB. Oncogene. 16(16). 2131–2139. 112 indexed citations
2.
Roff, Marilynn A., Jill L. Thompson, Manuel S. Rodríguez, et al.. (1996). Role of I Bα Ubiquitination in Signal-induced Activation of NF- B in Vivo. Journal of Biological Chemistry. 271(13). 7844–7850. 203 indexed citations
3.
Jones, David H., Brian W. McBride, Marilynn A. Roff, & Graham H. Farrar. (1995). Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies. Vaccine. 13(11). 991–999. 25 indexed citations
4.
Jones, David H., Brian W. McBride, Marilynn A. Roff, V.K. Maloney, & Graham H. Farrar. (1994). Purification and characterization of simian immunodeficiency virus (SIVmac) envelope glycoprotein GP130 from virus-infected cells. Vaccine. 12(3). 250–258. 12 indexed citations
5.
Oram, J. D., R. G. Downing, Marilynn A. Roff, et al.. (1991). Sequence Analysis of the V3 Loop Regions of the env Genes of Ugandan Human Immunodeficiency Proviruses. AIDS Research and Human Retroviruses. 7(7). 605–614. 36 indexed citations
6.
Farrar, Graham H., et al.. (1991). Characterisation of a series of human immunodeficiency virus isolates derived sequentially from a single patient. Journal of Medical Virology. 34(2). 104–113. 11 indexed citations
7.
Oram, J. D., R. G. Downing, Marilynn A. Roff, et al.. (1990). Nucleotide Sequence of a Ugandan HIV-1 Provirus Reveals Genetic Diversity from Other HIV-1 Isolates. AIDS Research and Human Retroviruses. 6(9). 1073–1078. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026